KLK14 and Familial prostate cancer: Expression of kallikrein-related peptidase 14 (KLK14), which is likely to have a major role in seminal clot liquefaction, indicates an adverse clinical outcome of prostate cancer patients as elevated KLK14 mRNA and protein levels have been associated with more aggressive tumors [4, 115].